Table of Contents
Johann Rupert's Remgro has signed an implementation agreement to take full ownership of Mediclinic Southern Africa in a $950 million deal that splits the private hospital group's assets along geographic lines between Remgro and its co-owner, Investment Holding Limited, a subsidiary of MSC Mediterranean Shipping Company.
Under the terms of the transaction, Mediclinic Holdings will sell its Swiss operations, the Hirslanden group, to IHL, while Remgro will purchase from Mediclinic Holdings all shares in Mediclinic Southern Africa. The two components will be executed simultaneously at a consideration of $950 million, equivalent to approximately R16.2 billion, on a 1:1 value exchange basis. The deal has a long-stop date of September 30, 2027. If one leg of the transaction closes and the other does not, the affected party becomes liable to pay the other its respective share in cash.
Remgro and IHL each currently hold 50% of Mediclinic Holdings. Once the restructuring completes, each partner will own its respective home market operation outright, while maintaining their joint interests in the Middle East, conducted through the EHH Group, and in the UK through Spire Healthcare.
The companies said the rationale is straightforward. Healthcare delivery has changed significantly in recent years, with pricing pressures, regulatory demands and the growing complexity of clinical practice creating a need for more agile, locally focused management. Splitting ownership along home market lines removes the friction of joint governance across geographically distinct systems and allows each party to tailor strategy to local dynamics without requiring alignment with a partner operating in a fundamentally different regulatory and reimbursement environment.
"The landscape continues to evolve at an increasing rate, driven by the growing prevalence of chronic diseases, ageing populations and an exponential expansion in medical knowledge and technology," Remgro said in the announcement. The company said the transaction would allow it to deepen trust with patients, clinicians and regulators in South Africa and to drive sustainable growth through greater operational focus.
Mediclinic Southern Africa is the third-largest private healthcare provider in Southern Africa by licensed beds, operating 50 hospitals with 8,991 inpatient beds and more than 21,400 employees. The network also includes the Intercare group of companies and ER24 EMS. Those businesses become wholly owned Remgro assets once the deal closes.
Remgro's connection to Mediclinic is longstanding. The company, which traces its origins to the Rembrandt Group founded by Anton Rupert in the 1940s, was Mediclinic's largest shareholder when Remgro and MSC jointly acquired the then-listed hospital group in a deal valued at approximately R75 billion in 2023. That transaction took Mediclinic private after a period on the Johannesburg and London stock exchanges.
Johann Rupert, Anton's son, chairs Remgro and holds effective control through the family's ownership of all unlisted B shares, which carry more than 40% of voting rights. His net worth is estimated at more than $13 billion, making him South Africa's richest person. The Rupert family's primary wealth originated from the spin-off of Richemont in 1988, which absorbed Rembrandt's international assets, while the South African interests remained in what became today's Remgro.
The transaction is conditional on approval from Swiss and South African regulatory authorities. No timeline has been specified beyond the long-stop date, but the companies said they aim to ensure continuity and stability for employees and patients throughout the process.
Mediclinic's financial performance has been strong heading into the restructuring. The group reported revenue of $2.57 billion for the six months ending September 30, 2025, a 10% increase, while adjusted EBITDA rose 23% and adjusted earnings climbed 91%, driven in large part by the Middle East operations.
The joint Middle East exposure gives both Remgro and IHL a continuing reason to collaborate even after the split. That region, which both parties described as a key market with strong expansion opportunities, remains a shared strategic interest and the one area where the 50:50 partnership framework will be maintained after the South Africa and Switzerland assets are separated.
